<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The systematic search for a deficiency in antithrombin III must be considered in case of: <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> in a young patient, <z:hpo ids='HP_0004850'>recurrent venous thrombosis</z:hpo> especially if these occurred under <z:chebi fb="5" ids="28304">Heparin</z:chebi>, venous <z:e sem="disease" ids="C0267406" disease_type="Disease or Syndrome" abbrv="">mesenteric infarction</z:e> since this type of <z:mp ids='MP_0005048'>thrombosis</z:mp> is rare and seems relatively frequent in case of congenital deficiency in antithrombin III, familial past history of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> in a woman desiring to undergo <z:chebi fb="0" ids="50114">estrogen</z:chebi>-<z:chebi fb="28" ids="17026">progesterone</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The most often used techniques are: study of antithrombin III activity by amidolytic method and titration by immunodiffusion </plain></SENT>
<SENT sid="2" pm="."><plain>Anti-<z:chebi fb="6" ids="28384">vitamin K</z:chebi> treatment is the only effective therapy proposed to patients suffering from a hereditary deficiency in antithrombin III </plain></SENT>
</text></document>